Monitoring and targeting the initial dimerization stage of amyloid self-assembly

Angew Chem Int Ed Engl. 2015 Feb 9;54(7):2062-7. doi: 10.1002/anie.201408744. Epub 2014 Dec 22.

Abstract

Amyloid deposits are pathological hallmark of a large group of human degenerative disorders of unrelated etiologies. While accumulating evidence suggests that early oligomers may account for tissue degeneration, most detection tools do not allow the monitoring of early association events. Here we exploit bimolecular fluorescence complementation analysis to detect and quantify the dimerization of three major amyloidogenic polypeptides; islet amyloid polypeptide, β-amyloid and α-synuclein. The constructed systems provided direct visualization of protein-protein interactions in which only assembled dimers display strong fluorescent signal. Potential inhibitors that interfere with the initial intermolecular interactions of islet amyloid polypeptide were further identified using this system. Moreover, the identified compounds were able to inhibit the aggregation and cytotoxicity of islet amyloid polypeptide, demonstrating the importance of targeting amyloid dimer formation for future drug development.

Keywords: amyloid inhibitors; amyloid self-assembly; complementation assays; fluorescence; self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / chemistry*
  • Amyloid / ultrastructure
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / ultrastructure
  • Drug Discovery
  • Fluorescence
  • Humans
  • Islet Amyloid Polypeptide / chemistry
  • Islet Amyloid Polypeptide / ultrastructure
  • Models, Molecular
  • Protein Aggregates / drug effects
  • Protein Aggregation, Pathological / drug therapy
  • Protein Aggregation, Pathological / pathology
  • Protein Multimerization* / drug effects
  • alpha-Synuclein / chemistry
  • alpha-Synuclein / ultrastructure

Substances

  • Amyloid
  • Amyloid beta-Peptides
  • Islet Amyloid Polypeptide
  • Protein Aggregates
  • alpha-Synuclein